Please use this identifier to cite or link to this item:
|Title:||Synthesis of novel bone-targeted agents for treatment of osteoporosis|
|Series/Report no.:||<b>Int</b>.<b>Cl</b>.<b><sup>7</sup> C 07 D</b>|
|Abstract:||Novel bone-targeted agents have been designed and synthesized by the combination of raloxifene and bisphosphonates. The anti-osteoporosis effect has been evaluated by bone mineral density (BMD) obtained from ovariectomized (OVX) mice <i>in vivo</i>. The results indicate that the compounds <b>8</b> and <b>9</b> not only prevent ovariectomy induced loss of bone but also enhance BMD to 7.09 and 12.59% compared to sham-operated control, respectively.|
|Appears in Collections:||IJC-B Vol.45B(01) [January 2006]|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.